Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Current Leases: 2019-2024

Historic Current Leases for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $117,000.

  • Silence Therapeutics' Current Leases rose 147.06% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $85,000, marking a year-over-year increase of 147.06%. This contributed to the annual value of $117,000 for FY2024, which is 48.68% down from last year.
  • As of FY2024, Silence Therapeutics' Current Leases stood at $117,000, which was down 48.68% from $228,000 recorded in FY2023.
  • Silence Therapeutics' 5-year Current Leases high stood at $551,974 for FY2022, and its period low was $117,000 during FY2024.
  • Its 3-year average for Current Leases is $298,991, with a median of $228,000 in 2023.
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 192.83% in 2022, then crashed by 58.69% in 2023.
  • Over the past 5 years, Silence Therapeutics' Current Leases (MRY) stood at $437,894 in 2020, then crashed by 56.95% to $188,495 in 2021, then surged by 192.83% to $551,974 in 2022, then crashed by 58.69% to $228,000 in 2023, then crashed by 48.68% to $117,000 in 2024.
  • Its last three reported values are $117,000 in FY2024, $228,000 for FY2023, and $551,974 during FY2022.